Intrinsic Value of S&P & Nasdaq Contact Us

RAPT Therapeutics, Inc. RAPT NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
25/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$30.71
-47.1%

RAPT Therapeutics, Inc. (RAPT) — Analyst outlook / Analyst consensus target is. Based on 15 analyst ratings, the consensus is bullish — 4 Buy, 11 Hold.

The consensus price target is $30.71 (low: $2.00, high: $55.00), representing a downside of 47.1% from the current price $58.01.

RAPT Stock — 12-Month Price Forecast

$30.71
▼ -47.06% Downside
Average Price Target
Based on 15 Wall Street analysts offering 12-month price targets for RAPT Therapeutics, Inc., the average price target is $30.71, with a high forecast of $55.00, and a low forecast of $2.00.
The average price target represents a -47.06% change from the last price of $58.01.
Highest Price Target
$55.00
Average Price Target
$30.71
Lowest Price Target
$2.00

RAPT Analyst Ratings

Hold
15
Ratings
4 Buy
11 Hold
Based on 15 analysts giving stock ratings to RAPT Therapeutics, Inc. in the past 3 months
Rating breakdown
Buy
4 27%
Hold
11 73%
27%
Buy
4 analysts
73%
Hold
11 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message